Disclosure: This site earns commissions from affiliate links (Amazon, Etsy, and others) at no extra cost to you.
Full affiliate disclosure →
Updated July 2026 · 9 min read
This article was created with AI assistance.
Heparin Drips: The ICU Nurse's Guide
⚕️ Medical Disclaimer: This content is for educational purposes only and is intended for licensed healthcare professionals. It does not constitute medical advice and should not replace clinical judgment, facility protocols, or physician orders. Always verify medications, doses, and procedures with your institution's guidelines.
The heparin drip is a nursing-driven medication — you titrate it off a nomogram, chase lab values every six hours, and hold the line between clot and hemorrhage. Two dangers define it: bleeding, and a paradoxical clotting disorder called HIT. Here is the practical picture.
The short version: A heparin (unfractionated heparin, UFH) infusion is titrated to a target using a weight-based nomogram, monitored by aPTT or anti-Xa levels (commonly every 6 hours until therapeutic). It treats and prevents clots — VTE, PE, ACS, and more. The two dangers to master are bleeding and heparin-induced thrombocytopenia (HIT), a dangerous immune reaction that paradoxically causes clotting. The reversal agent is protamine sulfate.
How heparin works
Unfractionated heparin binds antithrombin and dramatically accelerates its inactivation of thrombin (factor IIa) and factor Xa, preventing clot formation and propagation. Its effect is immediate when given IV, and — importantly for the ICU — it has a short half-life, so stopping the drip reverses much of the effect within a couple of hours. That controllability is why UFH is preferred over low-molecular-weight heparin in patients who are unstable, at high bleeding risk, or heading to procedures.
The weight-based nomogram
Heparin drips are almost always run off a standardized, weight-based protocol rather than physician-by-physician orders. The nurse follows the nomogram:
Step
Action
Initial bolus
Weight-based (e.g., ~80 units/kg), per protocol/indication
Initial infusion
Weight-based (e.g., ~18 units/kg/hr)
Monitoring
aPTT or anti-Xa ~6 hr after each change
Titration
Adjust rate up/down (and re-bolus or hold) per nomogram
Some indications (like ACS) use lower, capped dosing than VTE treatment — always use the correct protocol for the indication.
Bedside rule of thumb: The nomogram is the order. Draw the lab on time, act on the exact result, and document the change. The most common heparin errors are drawing the aPTT at the wrong time (too soon after a change) or from a line contaminated with heparin — both give false numbers that lead to wrong titrations.
aPTT vs anti-Xa monitoring
Traditionally heparin was titrated to the aPTT. Many institutions have moved to the anti-Xa assay, which more directly measures heparin's effect and is less confounded by conditions that distort the aPTT (like lupus anticoagulant, high factor VIII, or consumptive states). Know which your facility uses and what the therapeutic range is — they are not interchangeable numbers.
Bleeding — the everyday danger
Assess for bleeding continuously. Watch for obvious hemorrhage and the quiet kinds: a dropping hemoglobin, oozing from lines and puncture sites, blood in urine or stool, new neuro changes (intracranial bleed), abdominal or flank pain (retroperitoneal bleed), and a falling blood pressure with tachycardia. Minimize invasive procedures and intramuscular injections. If serious bleeding occurs, stop the infusion and anticipate an order for protamine sulfate, which reverses UFH — dosed by the amount of heparin given and its own risks (hypotension, allergic reactions, especially in patients with prior protamine or NPH insulin exposure or fish allergy).
HIT — the paradox that clots
Monitor the platelets. Heparin-induced thrombocytopenia (HIT) is an immune reaction, typically appearing 5–10 days into heparin exposure, in which antibodies activate platelets — causing a falling platelet count and, paradoxically, dangerous arterial and venous clotting, not bleeding. A drop in platelets of roughly 50% or more, or new thrombosis on heparin, should trigger a 4T score assessment and HIT workup. The management is to stop all heparin immediately (including flushes and LMWH) and switch to a non-heparin anticoagulant such as argatroban or bivalirudin. Do not simply lower the dose — HIT means no heparin at all.
Why CRNA students should know it
On the CRNA path, heparin is central to perioperative and cardiac anesthesia — you will manage full anticoagulation for cardiopulmonary bypass (monitored by ACT), reverse it with protamine, and screen for HIT. Understanding the antithrombin mechanism, the monitoring assays, and the bleeding/HIT dangers at the ICU bedside is exactly the pharmacology you will apply in the OR.
Bottom line
The heparin drip is nurse-driven precision: follow the weight-based nomogram, draw aPTT or anti-Xa correctly and on time, watch relentlessly for bleeding, monitor platelets for HIT, and know that protamine reverses it. Respect the two dangers and you run this drip safely. Learn it now and it carries into anesthesia practice.
This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.
We use cookies for analytics and advertising (Google AdSense). By continuing, you accept our
Privacy Policy.
EU/California visitors: you may opt out via your browser settings or
Google Ad Settings.
Get the ICU Notebook
Free investing strategies built for nurses. One email per week, no fluff.